Literature DB >> 15184103

Clinical phenotypes associated with DISC1, a candidate gene for schizophrenia.

D H R Blackwood1, W J Muir.   

Abstract

Genetic factors play an important part in the development of schizophrenia and bipolar disorder, and linkage analyses in families have successfully identified several chromosomal regions containing candidate genes. A single large pedigree has been described in which schizophrenia and depression segregate with a balanced chromosomal translocation involving the long arm of chromosome 1 and the short arm of chromosome 11. The gene named DISC1, disrupted at the chromosome 1 breakpoint, is a novel candidate gene that may have a role in the pathogenesis of schizophrenia. The cellular location and function of the protein coded by DISC1 is currently being investigated. The phenotype associated with DISC1 in the t (1;11) translocation family includes schizophrenia, schizoaffective disorder, recurrent major depression and bipolar disorder. Hence this locus is one of several now reported apparently showing linkage to both schizophrenia and bipolar disorder. The study of intermediate phenotypes or "endophenotypes" may clarify the relations between phenotype and genotype. Auditory event related potentials are EEG based physiological measures widely studied in schizophrenia. In particular the cognitive evoked potential, the P300 response generated during an "odd-ball" two-tone discrimination task consistently shows reduced amplitude in schizophrenia compared to controls. In members of the family with the t (1;11) translocation, P300 amplitude was reduced in relatives who carried the translocation compared to relatives with a normal karyotype. Furthermore the amplitude reduction was independent of the presence or absence of symptoms because asymptomatic translocation carriers showed similar P300 amplitude reduction as was found in translocation carriers who were diagnosed with schizophrenia, bipolar disorder or unipolar depression. The results confirm that subjects with schizophrenia who carry the t (1;11) translocation have similar phenotype to unrelated subjects with schizophrenia and a normal karyotype. Furthermore P300 amplitude may be a useful intermediate phenotype detecting the neuropathology of schizophrenia in "at risk" individuals even in the absence of clinical symptoms. Copyright 2004 FP Graham Publishing Co.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184103     DOI: 10.1007/bf03033294

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  33 in total

1.  Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300.

Authors:  D H Blackwood; M F Glabus; J Dunan; R E O'Carroll; W J Muir; K P Ebmeier
Journal:  Br J Psychiatry       Date:  1999-10       Impact factor: 9.319

2.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family.

Authors:  D H Blackwood; A Fordyce; M T Walker; D M St Clair; D J Porteous; W J Muir
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

Review 3.  Searching for alternative phenotypes in psychiatric genetics.

Authors:  Marion Leboyer
Journal:  Methods Mol Med       Date:  2003

Review 4.  Manic-depression genes and the new millennium: poised for discovery.

Authors:  M Baron
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  A twin study of genetic relationships between psychotic symptoms.

Authors:  Alastair G Cardno; Frühling V Rijsdijk; Pak C Sham; Robin M Murray; Peter McGuffin
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

6.  Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses.

Authors:  P Tienari; L C Wynne; J Moring; K Läksy; P Nieminen; A Sorri; I Lahti; K E Wahlberg; M Naarala; K Kurki-Suonio; O Saarento; P Koistinen; T Tarvainen; H Hakko; J Miettunen
Journal:  Acta Psychiatr Scand       Date:  2000-06       Impact factor: 6.392

7.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

Authors:  S M Lawrie; H Whalley; J N Kestelman; S S Abukmeil; M Byrne; A Hodges; J E Rimmington; J J Best; D G Owens; E C Johnstone
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

8.  Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease.

Authors:  V Arolt; R Lencer; A Nolte; B Müller-Myhsok; S Purmann; M Schürmann; J Leutelt; M Pinnow; E Schwinger
Journal:  Am J Med Genet       Date:  1996-11-22

9.  Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark.

Authors:  S S Kety; P H Wender; B Jacobsen; L J Ingraham; L Jansson; B Faber; D K Kinney
Journal:  Arch Gen Psychiatry       Date:  1994-06

10.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

View more
  18 in total

Review 1.  Gene-environment interplay in schizopsychotic disorders.

Authors:  Tomas Palomo; Trevor Archer; Richard M Kostrzewa; Rrichard J Beninger
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  Genetic models of schizophrenia and bipolar disorder: overlapping inheritance or discrete genotypes?

Authors:  Wolfgang Maier; Barbara Höfgen; Astrid Zobel; Marcella Rietschel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 3.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

4.  Genome-wide association identifies candidate genes that influence the human electroencephalogram.

Authors:  Colin A Hodgkinson; Mary-Anne Enoch; Vibhuti Srivastava; Justine S Cummins-Oman; Cherisse Ferrier; Polina Iarikova; Sriram Sankararaman; Goli Yamini; Qiaoping Yuan; Zhifeng Zhou; Bernard Albaugh; Kenneth V White; Pei-Hong Shen; David Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

5.  Heritability and molecular-genetic basis of the P3 event-related brain potential: a genome-wide association study.

Authors:  Stephen M Malone; Uma Vaidyanathan; Saonli Basu; Michael B Miller; Matt McGue; William G Iacono
Journal:  Psychophysiology       Date:  2014-12       Impact factor: 4.016

6.  Dynamic Network Connectivity: A new form of neuroplasticity.

Authors:  Amy F T Arnsten; Constantinos D Paspalas; Nao J Gamo; Yang Yang; Min Wang
Journal:  Trends Cogn Sci       Date:  2010-06-16       Impact factor: 20.229

Review 7.  Linking neurodevelopmental and synaptic theories of mental illness through DISC1.

Authors:  Nicholas J Brandon; Akira Sawa
Journal:  Nat Rev Neurosci       Date:  2011-11-18       Impact factor: 34.870

8.  DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia.

Authors:  Philip R Szeszko; Colin A Hodgkinson; Delbert G Robinson; Pamela Derosse; Robert M Bilder; Todd Lencz; Katherine E Burdick; Barbara Napolitano; Julia D Betensky; John M Kane; David Goldman; Anil K Malhotra
Journal:  Biol Psychol       Date:  2007-11-01       Impact factor: 3.251

Review 9.  Neurophysiological biomarkers for drug development in schizophrenia.

Authors:  Daniel C Javitt; Kevin M Spencer; Gunvant K Thaker; Georg Winterer; Mihály Hajós
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

Review 10.  DISC1 as a therapeutic target for mental illnesses.

Authors:  Takatoshi Hikida; Nao J Gamo; Akira Sawa
Journal:  Expert Opin Ther Targets       Date:  2012-11-06       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.